AIN
RepertoireBio

RepertoireBio

location_on London ,  United Kingdom

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

RepertoireBio is a human-data infrastructure company for biologics discovery. We address a structural failure in AI-led drug development: models are trained on sparse, synthetic, or non-human immune data. We unlock true biology-driven discovery.

Highlights

  • Fixes AI drug discovery’s core bottleneck: lack of human data
  • Oxford-developed platform now transitioning to industrial-scale deployment
  • Human-first discovery reduces immunogenicity and late-stage failure risk
  • Early validation via pilots with pharma, AI-native firms, and consortia
  • Compounding asset: proprietary paired human BCR–TCR database

Overview

Target NZ$ 4,600,000
Minimum NZ$ 225,000
Investment Raised NZ$ 225,000
Previous Rounds NZ$ 0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects